6 Nov 2021
Britain on Thursday (November 4) granted conditional authorization for Drugmaker Merck's COVID-19 pill, molnupiravir, the first pill shown to successfully treat COVID-19. It reduced hospitalizations, and deaths by around 50% in people severely infected with the coronavirus, according to interim clinical trial results announced on October 1. Due to the strong positive results, the Phase 3 trial is being stopped early at the recommendation of an independent group of medical advisers.
2 mins ago
DW speaks to exiled Cambodian opposition leader Sam Rainsy, a co-founder of the Cambodian National Rescue Party (CNRP), about upcoming local elections in Cambodia and about Prime Minister Hun Sen's stance toward Myanmar's junta.
18 mins ago
Nigeria Energy 2022's flagship conference brought together key stakeholders from Nigeria's energy sector, from government ministries and regulators to gas companies supplying fuel to grid-connected plants to independent power producers, distribution companies, and the bodies mandated to facilitate the development of renewable energy and off-grid solutions.
1 hour ago
Find these stories and much more when you grab a copy of The Guardian on Tuesday.
1 hour ago
In the second part of her story, Ghanaian medical student Dorcas Djabatey, who was studying in Ukraine before the war broke out, talks about her escape from Sumy, why she feels let down and her future.
2 hours ago
To promote the usage of typewriters in an age of mobile phones and computers, a man in India's central Indore city has collected around 450 typewriters that type in different languages.